Powered By
Clinical Trial Opportunity
Researchers at Yale are enrolling participants with early stage ER+ breast cancer who have completed treatment. The study uses a ctDNA blood test to detect early signs of recurrence and improve patient outcomes.
ctdna newsletter(3)
GRASP cancer
ctDNA Guided Treatment for
Patients with ER+ Breast
Cancer Who Have Completed
Treatment
A ctDNA Blood Test for Cancer
This study aims to use a blood test (ctDNA) to find out which patients might benefit
from extra treatment… read more
This is what KarenFischbeck posted a while ago about Signatera. Signatera is a personalized, blood-based molecular residual disease (MRD) test by Natera that detects circulating tumor DNA (ctDNA) to identify cancer recurrence up to two years earlier than imaging. It is tailored to a patient's specific tumor mutations, offering high sensitivity for monitoring cancer,, including colorectal, breast, lung, and bladder cancers. The test is covered by Medicare for various solid tumors, with financial assistance programs available. I just requested this from my Oncologist and had the blood drawn done a couple of days ago. They already have my tissue sample when I had my surgery.
This sounds wonderful and I would do it if I qualified. Currently in a drug trial
for a c diff vaccine. I had exchange surgery last Dec., probably going to have a revision surgery in May or June. I was ER+, PR+, HER2-. if there is ever a clinical trial I can do in future years with those diagnosis parameters, I will. Everything helps our future generations.
Are you interested in learning about clinical trials for early-stage ER+ breast cancer that monitor for recurrence?
This Yale study sounds promising! It's using ctDNA (circulating tumor DNA) blood tests to catch early signs of recurrence in people who've finished treatment for early-stage ER+ breast cancer.
Here's what Show Full Answer
I haven’t had c diff, but was tagged/asked to be in the trial simply because of my high number of hospital & doc office visits. It puts us all in a higher risk bracket.
This isn’t the first ever c diff vaccine trial, but one that is using a different vaccine
“recipe” that will hopefully be more affective. Trial and error, then tweak, the story of medicine. (and life!)
Hi @A MyBCTeam Member I am doing the Signatera test next month. I’m nervous & excited all in one to try it. My oncologist said that if my insurance doesn’t cover it, the signatera people usually won’t charge a patient then. I hope it’s true, I don’t need another Dr bill 😩.
Join
Your Privacy Choices
